Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 for Foot Pain Houston Podiatrist Explains FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and Some peptides are FDA approved drugs. Some are legal supplements. Some are neither. The same word, peptide, covers all three categories. The regulatory status of the specific compound is what determines legality. The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype